
Available for Type 2 DiabetesSay Goodbye to Multiple Daily Injections
Tandem Diabetes Care insulin pumps deliver best-in-class outcomes that can make type 2 diabetes management easier. Powered by Control-IQ+ technology, they automatically deliver or suspend insulin based on CGM values.

Decrease in A1c
Patients with an A1c of 9% or greater saw a 2.3% drop1

Everyone Benefits
All other patients groups saw a 0.9% reduction in A1c1
Control-IQ+ not only has better outcomes than MDI, but it reduces the burden of diabetes management thanks to significantly fewer injections.* Because nobody likes shots.
Control-IQ+ | MDI |
|---|---|
Conveniently automates insulin delivery, day and night |
You have to manually inject insulin |
Intuitive AutoBolus feature† helps with missed meal dose |
Requires you to manually fix blood sugar |
Discreetly dose for meals with the push of a button |
You always need to carry your injections with you |
Only 122 Infusion Sets Insertions
on average per year*
1,460 syringe or pen injections
on average per year*



A Tandem Diabetes Care Specialist will help you get started.
Tighter Control
Predicts glucose levels 30 minutes ahead and automatically adjusts or suspends insulin every five minutes.
Improved Outcomes
63% of study participants using Control-IQ+ reached the target of 7.5 A1c or less.1
The Only System with AutoBolus
Better A1c results, even for people who occasionally miss meal boluses.1
Easy to Use
Control-IQ+ does the calculations for you, eliminating a lot of the guesswork and easing the burden.
See how the pump that's #1 rated in overall satisfaction by healthcare providers3 can help you manage type 2 diabetes.

Tandem Mobi System
Impressively small and can be worn almost anywhere,‡ Tandem Mobi gives you more options for how you manage your diabetes.
Available Features

t:slim X2 Insulin Pump
With a sleek color touchscreen, this all-in-one insulin pump integrates seamlessly into your life like a sophisticated, modern device.
Available Features
What's next?
Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.
Frequently Asked Questions

Try Our PumpsFree Virtual Demos
Test drive the easy-to-use interfaces of either Tandem Mobi or t:slim X2 automated insulin delivery systems, with no obligation.
* Based on four injections per day for shots and one site change every three days for pumps.
† If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ+ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value.
‡ Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.
§ The mobile app requires a compatible smartphone model and operating system (sold separately). Only available to pump users who reside in the United States.
^ CGM sold separately.
** Adhesive sleeve sold separately.
†† Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, an app update, a remote software update on the t:slim X2 insulin pump and additional training.
References
1. Kudva YC, et al. N Engl J Med. 2025;392(18):1801-1812. doi: 10.1056/NEJMoa2415948.
2. Seagrove PWD Survey: Nov. 2024.
3. Seagrove Partners HCP Perspectives (Devices), September 2024 Insulin Delivery Section N=269
4. As of June, 2025. Data on file, Tandem Diabetes Care.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
Tandem t:slim mobile app: The feature set available within the Tandem t:slim mobile app is dependent on the pump software version and the compatible smartphone’s model and operating system (OS).
The Display and Data Upload feature set provides a secondary display of pump and continuous glucose monitoring (CGM) information, including display of your pump alerts and alarms, and enables wireless uploading of pump and CGM data to the Tandem cloud through an internet or wireless data connection. Standard carrier data rates may apply.
The Bolus Delivery plus Display and Data Upload feature set additionally allows users to request, stop, and cancel a bolus on the pump from the Tandem t:slim mobile app. At least one smartphone security setting must be enabled to utilize the Bolus Delivery feature of the Tandem t:slim mobile app.
WARNING: Always rely on your pump to make therapy decisions when using a smartphone that is incompatible with the Bolus Delivery feature.
PRECAUTIONS: Always rely on your pump to make therapy decisions if using a smartphone that is incompatible, the smartphone is lost or damaged, or the smartphone loses Bluetooth® connectivity with your pump. Important pump alerts and alarms are only received as app notifications when enabled and the app is either active or running in the background.

